Jha, N.K.; Sharma, C.; Meeran, M.F.N.; Jha, S.K.; Dwivedi, V.D.; Gupta, P.K.; Dey, A.; Kesari, K.K.; Ojha, S.
Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19. Immuno 2021, 1, 285-304.
https://doi.org/10.3390/immuno1030020
AMA Style
Jha NK, Sharma C, Meeran MFN, Jha SK, Dwivedi VD, Gupta PK, Dey A, Kesari KK, Ojha S.
Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19. Immuno. 2021; 1(3):285-304.
https://doi.org/10.3390/immuno1030020
Chicago/Turabian Style
Jha, Niraj Kumar, Charu Sharma, Mohamed Fizur Nagoor Meeran, Saurabh Kumar Jha, Vivek Dhar Dwivedi, Piyush Kumar Gupta, Abhijit Dey, Kavindra Kumar Kesari, and Shreesh Ojha.
2021. "Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19" Immuno 1, no. 3: 285-304.
https://doi.org/10.3390/immuno1030020
APA Style
Jha, N. K., Sharma, C., Meeran, M. F. N., Jha, S. K., Dwivedi, V. D., Gupta, P. K., Dey, A., Kesari, K. K., & Ojha, S.
(2021). Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19. Immuno, 1(3), 285-304.
https://doi.org/10.3390/immuno1030020
